arrow_back Back to App

STOP Fentanyl Act: Combating Addiction and Overdoses

This act aims to combat the opioid crisis, particularly concerning fentanyl. It introduces new programs for monitoring, treatment, and overdose prevention, while also increasing access to life-saving medications and supporting individuals seeking help. Citizens can expect better access to addiction treatment and increased safety in the face of the fentanyl threat.
Key points
Enhanced Drug Surveillance: Improved data collection on fentanyl and other opioids will help understand the problem and act more effectively.
Increased Access to Treatment: The act facilitates access to addiction treatment, including medication-assisted treatment, also in prisons and rural areas.
Protection for Lifesavers: Individuals administering aid in overdose situations, including naloxone, will be protected from legal liability.
Support for Harm Reduction Programs: Funding for programs preventing overdoses and the spread of infectious diseases.
Research and New Technologies: Investments in developing technologies for detecting fentanyl in illicit substances.
Naloxone Price Transparency: Manufacturers of naloxone will be required to report costs and prices, potentially impacting its availability.
Support for Law Enforcement: Training for law enforcement on safe fentanyl detection and handling.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2366
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
Process start date: 2021-04-05
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

STOP Fentanyl Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2366.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-04-05.

What are the main provisions?

Key points include:

  • Enhanced Drug Surveillance: Improved data collection on fentanyl and other opioids will help understand the problem and act more effectively.
  • Increased Access to Treatment: The act facilitates access to addiction treatment, including medication-assisted treatment, also in prisons and rural areas.
  • Protection for Lifesavers: Individuals administering aid in overdose situations, including naloxone, will be protected from legal liability.
  • Support for Harm Reduction Programs: Funding for programs preventing overdoses and the spread of infectious diseases.
  • Research and New Technologies: Investments in developing technologies for detecting fentanyl in illicit substances.
  • Naloxone Price Transparency: Manufacturers of naloxone will be required to report costs and prices, potentially impacting its availability.
  • Support for Law Enforcement: Training for law enforcement on safe fentanyl detection and handling.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kuster, Ann M. [D-NH-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health Security Courts and Law